The potential for synthetic biology and biotechnology is vast; we all have an opportunity to create the future together - Ryan Bethencourt


image by: Idaho National Laboratory

HWN Suggests

Why Biotech Is Cultivating a Hotbed of Entrepreneurs Right Now

True entrepreneurs have an in-built necessity to change the world for the better and leave their impact on it. And what better area to do that in than biotech? The total global biotech market is valued at almost $415 billion in 2017. Biotech is not only a thriving industry with a wealth of possibilities; it allows daring entrepreneurs to leave their stamp on world problems. Helping improve surgery, develop cures, or vaccinate against deadly diseases.

According to Fortune, more and more startups in the healthcare and biotech industry are beginning to make their mark. The reasons for this are various. There is generally low competition thanks to the high specialty needed. On top of…

read full article


 Why Biotech Is Cultivating a Hotbed of Entrepreneurs Right Now

True entrepreneurs have an in-built necessity to change the world for the better and leave their impact on it. And what better area to do that in than biotech?

Bio-IT World

Bio-IT World is the flagship publication of Cambridge Healthtech Institute (CHI), is the leading source of news on technology and strategic innovation in drug discovery, development, and clinical trials.


The principal aim of BioNews is to provide accurate, balanced and timely news and comment on genetics, assisted conception, embryo/stem cell research and related areas.


BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to source core information on specific bio-related topics, to collate relevant data associated with each topic and to point the user to relevant knowledge resources.


BioSpace is globally recognized as the leading provider of web-based resources and information to the life science industry.


BioWorld publishes information that is researched and written by the top business and science reporters in the industry


FierceBiotech monitors biotech & pharma deals, FDA decisions, clinical trials, and more.

Genetic Engineering & Biotechnology News

Genetic Engineering & Biotechnology News (GEN), the only high-frequency publication dedicated to biotech news, from bench to business, was introduced in 1981 as the first biotechnology trade publication.


NPG publishes journals and online databases across the life, physical and applied sciences and, most recently, clinical medicine.

The Bioinformatics Organization, Inc. serves the scientific and educational needs of bioinformatic practitioners and the general public.

Biotechnology Institute

The Institute's e-mail newsletter, the News Digest, looks at the world of biotechnology education, with links to current articles, Institute news and a schedule of upcoming workshops and other events.

European Molecular Biology Laboratory

Researchers at the European Molecular Biology Laboratory [EMBL] and the Institute for Atomic and Molecular Physics [AMOLF], The Netherlands, have now decoded a molecular mechanism that plays an important role in the development of a cell's shape.

International Centre for Genetic Engineering and Biotechnology

An international organisation dedicated to advanced research and training in molecular biology and biotechnology, with special regard to the needs of the developing world.


NCBI creates public databases, conducts research in computational biology, develops software tools for analyzing genome data, and disseminates biomedical information - all for the better understanding of molecular processes affecting human health and disease.

Society For Biomaterials

The Society For Biomaterials is a professional society which promotes advances in all phases of materials research and development by encouragement of cooperative educational programs, clinical applications, and professional standards in the biomaterials field.

Surfaces in Biomaterials Foundation

The Surfaces in Biomaterials Foundation is dedicated to exploring creative solutions to technical challenges at the BioInterface by fostering education and multidisciplinary cooperation among industrial, academic, clinical and regulatory communities.


We’re a company that takes on the toughest health challenges. But we do more than treat diseases—we aim to make a remarkable impact on people’s lives. We are AbbVie, a highly focused research-driven biopharmaceutical company.

Advanced Biotechnologies

Our company was founded by a handful of people who shared the same passion—their goal was never to be the biggest, but to be the best, and now we manufacture and sell the purest viral reagents to approximately 50 countries worldwide. My team and I strive daily to continue my father’s legacy, and look forward to a better future for all.

Ajinomoto Bio-Pharma

At Ajinomoto Bio-Pharma Services, our mission is to help improve the health of humankind. Our ultimate goal is to provide adaptive solutions, responsive service, trusted partnerships and peace of mind to our customers. Through innovation, accountability, compliance, communication and teamwork, we take pride in knowing our efforts are helping countless patients for years to come.


Through the transformative power of our science, Alexion has delivered life-changing therapies to patients suffering from rare diseases. We have pioneered the complex field of complement biology and delivered solutions to challenges that once seemed impossible for patients living with rare and devastating diseases.


Headquartered in Dublin, Ireland, we are a global pharmaceutical leader focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world.


Alnylam is leading the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of patients who have limited or inadequate treatment options. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach for the treatment of a wide range of debilitating diseases with high unmet medical need.


At Amgen, we believe in a “biology first” approach. We use cutting-edge science and technology to study the subtlest biological mechanisms in search of therapies that will improve the lives of those who suffer from serious diseases. Amgen believes the cure for disease can be found inside each and every one of us.

Arcadia Biosciences

We innovate crops to provide high-value, healthy food ingredients to help meet consumer demand for a healthier diet. We’ve also developed a portfolio of agronomic traits that enable farmers around the world to be more productive amidst challenging economic and environmental conditions.


On the forefront of healthcare change to turn innovative science into value for patients.

Astex Pharmaceuticals

Our corporate mission is to discover and develop novel therapeutics with a primary focus in cancer and a developing focus in CNS disorders.


Improving health is one of the toughest challenges facing the world today. As a global biopharmaceutical company, AstraZeneca has a key contribution to make by providing innovative medicines for some of the world’s most serious diseases.

Avanir Pharmaceuticals

Every day at Avanir Pharmaceuticals, Inc. we focus on the research, development and commercialization of novel medical and pharmaceutical treatments for people with central nervous system disorders. That focus, along with the deep-seated passion of our people, is fueling the development of innovative medical solutions.

Bausch Health

Bausch Health is focused on improving people’s lives with our health care products. We are delivering on our commitments to patients, health care providers, other stakeholders and society, as we build an innovative company dedicated to advancing global health.


We help diagnose, alleviate or cure diseases, improve the global food supply and contribute to an active, modern lifestyle.


BIOVIA, a brand of Dassault Systèmes, provides a scientific collaborative environment for advanced biological, chemical and materials experiences that help science- and process-driven companies develop higher quality products faster and more cost effectively. BIOVIA’s sophisticated enterprise system of modeling, simulation, laboratory, quality and process data management allows customers to discover, design, deploy and deliver innovative sustainable and competitive products to consumers globally.

Boehringer Ingelheim

At Boehringer Ingelheim we are driven by the desire to serve mankind by improving human and animal health. As a successful, family owned company we plan in generations. We work together globally and with integrity. OUR FOCUS articulates who we are and what we strive for, how we work and what we want to achieve.

Bristol-Myers Squibb

We are a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.


Celgene is a global biopharmaceutical company committed to improving the lives of patients worldwide. At Celgene, we seek to deliver truly innovative and life-changing treatments for our patients.


Cyclacel is using cell cycle control, transcriptional regulation and DNA damage response biology to develop innovative, targeted medicines for cancer and other proliferative diseases.


Harnessing the power of the immune system to help extend patients’ lives.


We are developing cutting-edge vaccines by utilizing our innovative adjuvant technology and our expertise of Toll-like Receptor (TLR) biology to modulate the immune system.


Eisai positions "neurology" and "oncology" as two strategically important areas where we can discover "Ricchi", areas where patients true needs remain unmet and we can become a front-runner. Accordingly, we are promoting drug discovery activities in these two areas.


At Endo International, our generics and specialty branded products play an important role in helping millions of patients lead healthier lives. Through our operating companies, we are dedicated to delivering quality medicines to patients in need through excellence in development, manufacturing and commercialization.


We create first-in-class medicines to treat chronic and life-threatening conditions such as anemia, idiopathic pulmonary fibrosis, and pancreatic cancer.


Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Our transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis.


Geron is a late-stage clinical biopharmaceutical company focused on the development and potential commercialization of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.


At Gilead, we strive to transform and simplify care for people with life-threatening diseases around the world.


Driving scientific innovation to deliver the next generation of transformational medicines and vaccines for patients.


We think it’s time to give the world a therapy that targets the problem and only the problem. A therapy that targets cancer cells where they live, not where you live. Because liberating lives is what we live for. At ImmunoGen, our science targets cancer cells and our hearts target a better now.


Incyte is a biopharmaceutical company focused on the discovery, development and commercialization of innovative medicines that will address serious unmet medical needs in oncology and other diseases.


Made up by some of the brightest minds in the fields of immunotherapy, vaccines, biotech, and business, Inovio is ceaselessly challenging ourselves to employ immuno-ingenuity to solve critical unmet needs in global health.


We are a community of scientists and creative innovators working to build a safer, healthier planet, and a more promising future. Our unique expertise is in the design and engineering of astonishing living systems, from T-cells that battle cancer to non-browning apples.


There are still many diseases for which there is no cure, and effective drugs must be found. Although we have contributed to the solutions for some of these problems, we will continue our research efforts, because so much more needs to be done - Dr. Paul Janssen


Lilly unites caring with discovery to create medicines that make life better for people around the world.

Mallinckrodt Pharmaceuticals

Mallinckrodt Pharmaceuticals is a multibillion dollar specialty pharmaceutical company focused on our mission: Managing Complexity. Improving Lives. We provide medicines to address unmet patient needs, stemming from 150 years of using our unique strengths, experience and expertise to help improve people’s lives. Discover how our rich history of innovation and patient-centered solutions has helped influence our vision for the future.


As an organization, our core values are driven by a desire to improve human life, achieve scientific excellence, operate with the highest standards of integrity, expand access to our products and employ a diverse workforce that values collaboration.


Mylan is a global pharmaceutical company committed to setting new standards in healthcare and providing 7 billion people access to high quality medicine.


Bringing hope to millions of patients by creating new medicines that treat serious medical needs.


Using our novel R&D platform for the advancement of life-changing medicines, we focus on developing and commercializing treatments for neurological and endocrine related disorders.


At Novartis, we invest in the most promising frontiers of science, the most exciting innovations in the business of medicine, and the most significant healthcare needs.

Novo Nordisk

At Novo Nordisk, we are driving change to defeat diabetes and other serious chronic diseases.


Our purpose is grounded in our commitment to fund programs that provide public benefit, advance medical care and improve patient outcomes. Our belief is that all people deserve to live healthy lives. This drives our desire to provide access to medicines that are safe, effective, and affordable.


Plexxikon® is a leader in the discovery and development of novel, small molecule pharmaceuticals. The company has utilized its proprietary discovery platform to successfully develop a portfolio of competitively differentiated clinical and preclinical stage programs in a number of therapeutic areas and disease indications. P


We believe it’s urgent to deliver medical solutions right now – even as we develop innovations for the future. We are passionate about transforming patients’ lives. We are courageous in both decision and action. And we believe that good business means a better world.


We are focused on constant innovation to improve patients’ lives and arming healthcare providers with life-changing solutions in gastroenterology.

Sanofi Genzyme

We develop specialty treatments for debilitating diseases that are often difficult to diagnose and treat, providing hope to patients and their families.


Sarepta is at the forefront of precision genetic medicine, having built an impressive and competitive position in Duchenne muscular dystrophy (DMD) and more recently in gene therapies for 6 Limb-girdle muscular dystrophy diseases (LGMD), Charcot-Marie-Tooth (CMT), MPS IIIA, Pompe and other CNS-related disorders...

Takeda Oncology

Our mission remains constant — we endeavor to deliver novel medicines to patients with cancer worldwide through our commitment to science, breakthrough innovation and passion for improving the lives of patients.


Taro is a research-based international pharmaceutical company that was established on the principal that research and development would be the cornerstone of its growth strategy. Providing quality products through scientific innovations, diligence and precision is the goal of all of Taro's research programs.


We wake up with pride every morning knowing that we help people to live better days while ensuring the highest standards of compliance and business integrity in everything we do. This is how we improve health and enable people to live better, healthier lives.

Teva Pharmaceutical Industries

Our mission is to be a global leader in generics and biopharmaceuticals, improving the lives of patients across the globe.

The Medicines Company

The Medicines Company is a biopharmaceutical company whose purpose is to halt the deadly progression of atherosclerosis and the cardiovascular risk created by high levels of LDL-C, or bad cholesterol.

Titan Phamaceuticals

Titan is advancing the treatment of select chronic diseases by developing therapeutics based on its proprietary long-term, continuous drug delivery platform, ProNeura.


Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases.


We are a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system (CNS) conditions.


XOMA plays a unique role in helping biotech companies achieve their goal of improving human health. We do this by acquiring the economic rights to future milestone and royalty payments associated with partnered pre-commercial clinical candidates.


Science-driven and focused on developing the next generation of immuno-oncology gene and cell therapies, Ziopharm has two distinct clinically advanced paths to stimulate, tune, and control the body’s immune response to fight blood cancers and solid tumors.

Introducing Stitches!

Your Path to Meaningful Connections in the World of Health and Medicine
Connect, Collaborate, and Engage!

Coming Soon - Stitches, the innovative chat app from the creators of HWN. Join meaningful conversations on health and medical topics. Share text, images, and videos seamlessly. Connect directly within HWN's topic pages and articles.

Be the first to know when Stitches starts accepting users

Stay Connected